Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - GB
$ 1.39
-6.08 %
$ 2 M
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-1.5 M
OPERATING CASH FLOW
24.9 K
INVESTING CASH FLOW
1.49 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Akanda Corp.
| Net Income | -32.3 M |
| Depreciation & Amortization | 4.28 M |
| Capital Expenditures | -1.5 K |
| Stock-Based Compensation | 0 |
| Change in Working Capital | 3.15 M |
| Others | 23.5 M |
| Free Cash Flow | -1.5 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (32.3) | (11.7) | (8.1) | (2.3) | (1.4) |
| Depreciation & Amortization | 4.3 | 3.8 | 0.3 | 0.2 | 0.2 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0 | 0.6 | 0 | 0 | 0 |
| Other Operating Activities | 23.3 | (6.3) | 1.9 | 0.7 | 0.5 |
| Change in Working Capital | 3.1 | 2.2 | (0.6) | 30.4 K | 59.7 K |
| Cash From Operations | (1.5) | (11.5) | (6.6) | (1.4) | (0.6) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 1.5 K | (0.3) | (0.6) | (0.4) | (0.7) |
| Other Items | 26.4 K | (3.9) | 0 | 6.93 K | 6.85 K |
| Cash From Investing Activities | 24.9 K | (4.2) | (0.6) | (0.4) | (0.7) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 1.5 | (0.8) | 6.2 | 1.0 | 2.1 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 5.1 | 0 | 0 |
| Cash From Financing Activities | 1.5 | 14.1 | 11.2 | 1.0 | 2.1 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (0.2) | (3.2) | 3.5 | (0.8) | 0.8 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (1.5) | (11.8) | (7.1) | (1.8) | (1.3) |